End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
24.86 CNY | -1.66% | +6.33% | +10.20% |
04-22 | Perfect Group Corp., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-08 | Perfect Group Completes Acquisition of Shanenkang Biotechnology's 52% Stake | MT |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
Strengths
- Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
Weaknesses
- The company is not the most generous with respect to shareholders' compensation.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- Over the past four months, analysts' average price target has been revised downwards significantly.
Ratings chart - Surperformance
Sector: Personal Products
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+10.20% | 346M | - | ||
+12.48% | 46.02B | B- | ||
-1.39% | 18.94B | A- | ||
0.00% | 4.25B | C+ | ||
+4.80% | 2.65B | - | C- | |
-12.50% | 1.59B | C- | ||
+47.10% | 1.33B | - | ||
+15.85% | 947M | - | ||
+21.37% | 807M | B | ||
+26.18% | 440M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 603059 Stock
- Ratings Perfect Group Corp., Ltd